BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12526227)

  • 21. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
    J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
    Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
    Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Shen JK; Dong LH; Qi H; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study.
    Ogata Y; Fujita H; Yamana H; Sueyoshi S; Shirouzu K
    World J Surg; 2003 May; 27(5):584-9. PubMed ID: 12715228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa.
    Homer JJ; Prentice MG; Cawkwell L; Birchall M; Greenman J; Stafford ND
    Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1110-4. PubMed ID: 14568798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
    Shimada Y; Maeda M; Watanabe G; Imamura M
    Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma].
    Guo X; Cao SM; Hong MH; Zhang CQ; Han AJ; Xiang YQ; Hou JH; Min HQ
    Ai Zheng; 2004 Oct; 23(10):1171-5. PubMed ID: 15473929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.
    Friedrich RE; Klapdor R; Hagel C; Bartel-Friedrich S
    Anticancer Res; 2010 May; 30(5):1765-6. PubMed ID: 20592375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
    De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G
    Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.
    Kozłowski M; Laudański W; Mroczko B; Szmitkowski M; Milewski R; Łapuć G
    Adv Med Sci; 2013; 58(2):227-34. PubMed ID: 23773968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.